Some progress today. Among these three big companies, Merck is the one with most possibility to release. Merck has an expanded access program for their PDL1 drug MK3475, which can be used for 12-years-old. insights.idispharma/acton/fs/blocks/showLandingPage/a/8349/p/p-0047/t/page/fm/0 Shands says they will help us to accelerate the process. I contacted Mercks expanded program operations executive. She is nice and gets the contact of Joeys oncologist. Hopefully more progress with Merck next week. Anyone has connection with Mercks leadership? I know just last week, Merck refused the PDL1 to another 25 year old woman, who has exactly the same subtype with Joey.
Posted on: Sat, 19 Apr 2014 00:45:20 +0000